DR Agarwals Health Care L
- ISIN
- INE943P01029
- Instrument key
- NSE_EQ|INE943P01029
as of 21/11/2026, 2:40:54 pm
- Open
- ₹549.60
- Day high
- ₹557.90
- Day low
- ₹547.55
- Prev. close
- ₹553.10
- Volume
- 86.1K
- VWAP
- ₹554.30
02/Price history
Price chart
Max · monthly candles. Hover the chart for the OHLC of any candle; the table below holds the same data row by row.
- Change · MAX
- +38.00%401.00 → 553.40
- Period high
- ₹571.901/11/2026
- Period low
- ₹327.001/5/2025
- From high
- -3.23%+69.24% from low
- Avg volume
- 96.17 L21.16 Cr total
- Volatility · ann.
- 35.2%22 candles · 12 up / 10 down
Candle data22 rows of open, high, low, close and volumeShowHide
| 1 Nov 2026 | 509.20 | 571.90 | 492.50 | 553.40 | +8.68% | 79.40 | 31.24 L |
| 1 Oct 2026 | 472.70 | 529.00 | 452.00 | 509.20 | +7.72% | 77.00 | 47.56 L |
| 1 Sept 2026 | 513.75 | 528.80 | 472.50 | 479.30 | -6.71% | 56.30 | 63.69 L |
| 1 Aug 2026 | 477.90 | 567.75 | 477.35 | 513.20 | +7.39% | 90.40 | 5.76 Cr |
| 1 Jul 2026 | 479.95 | 505.00 | 463.00 | 478.00 | -0.41% | 42.00 | 19.65 L |
| 1 Jun 2026 | 489.00 | 492.25 | 437.00 | 478.95 | -2.06% | 55.25 | 15.12 L |
| 1 May 2026 | 445.10 | 496.45 | 437.00 | 484.10 | +8.76% | 59.45 | 19.10 L |
| 1 Apr 2026 | 412.60 | 469.75 | 407.70 | 445.10 | +7.88% | 62.05 | 22.74 L |
| 1 Mar 2026 | 421.00 | 455.15 | 401.00 | 406.55 | -3.43% | 54.15 | 43.83 L |
| 1 Feb 2026 | 431.65 | 463.95 | 428.00 | 451.70 | +4.64% | 35.95 | 22.38 L |
Historical price and volume data · Showing 1–10 of 22
03/Valuation & returns
Key ratios vs sector
Company value benchmarked against the sector median. The ratio set is sector specific — banks report NIM, CASA and Net NPA instead of EV/EBITDA.
Price ÷ earnings per share
Worse than sector by 114%
Price ÷ book value per share
Worse than sector by 96%
Net income ÷ total assets
Worse than sector by 54%
Net income ÷ shareholders' equity
Worse than sector by 54%
EBIT ÷ capital employed
Worse than sector by 46%
Liquid assets ÷ current liabilities
Worse than sector by 62%
Enterprise value ÷ EBITDA
Worse than sector by 82%
04/Business
About the company
Sector: Healthcare
Dr. Agarwal's Health Care Ltd is an India-based company, which operates as a health care institution. The Company is engaged in running, owning and managing eye care hospitals, optical, pharmacies, etc. and related services. It provides a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sells optical, contact lenses and accessories, and eye-care related pharmaceutical products. Its services include surgeries and consultations, diagnoses and non-surgical treatments. Its surgery services include cataract surgery, refractive surgery, and other surgery. Its consultations, diagnoses and non-surgical treatments offer doctor consultation services, diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment. It provides a range of glasses, lenses, contact lenses and frames at its facilities.
- ₹17,561 Cr
- $1.95B
reported in crore
reported in billion
Market capitalisation is reported at the sector-constituent level, not the standalone company level.
05/Profit & loss
Standalone income statement
Annual figures in ₹ crore. Growth marked reported is provided; margins are derived.
- Revenue · Mar 2026
- ₹1,800 Cr+64.00% vs Mar 2025
- Net profit · Mar 2026
- ₹107 Cr+389.38% vs Mar 2025
- Operating margin
- 8.6%was 3.5%
- Revenue CAGR · 4p
- 43.0%profit 50.3% · op —
| Revenue | 1,800 | 1,098 | 882 | 615 |
|---|---|---|---|---|
| Revenue growthreported | 64.0% | 24.4% | 43.4% | — |
| Operating profit | 155 | 39 | 45 | -6 |
| Operating profit growthreported | 302.4% | -13.6% | 864.7% | — |
| Operating marginderived | 8.6% | 3.5% | 5.1% | -0.9% |
| Net profit | 107 | 22 | 24 | 32 |
| Net profit growthreported | 389.4% | -8.0% | -24.6% | — |
| Net marginderived | 6.0% | 2.0% | 2.7% | 5.1% |
| EPS — basic₹/share, annual | 1.25 | 0.74 | 0.90 | 1.34 |
Figures in ₹ crore. Margin rows are computed from the reported values.
Full annual line itemsRevenue, other income, expenses, tax, EPSShowHide
| Revenue | 1,293 | 1,044 | 835 | 598 |
|---|---|---|---|---|
| Other Income | 33 | 54 | 47 | 18 |
| Total Revenue | 1,327 | 1,098 | 882 | 615 |
| Total Expenses | 1,256 | 1,045 | 828 | 592 |
| Profit Before Tax | 64 | 39 | 45 | -6 |
| Tax | 25 | 17 | 21 | -37 |
| Profit After Tax | 39 | 22 | 24 | 32 |
| EPS - Basic | 1.25 | 0.74 | 0.90 | 1.34 |
| EPS - Diluted | 1.25 | 0.73 | 0.90 | 1.34 |
This breakdown is available annually, even when the summary above is quarterly. EPS rows are per share.
06/Balance sheet
Standalone balance sheet
Only annual balance sheets are available — the quarterly filter does not apply here. Figures in ₹ crore; net worth is assets minus liabilities.
- Total assets · Mar 2026
- ₹2,961 Cr+4.39% YoY
- Total liabilities
- ₹970 Cr
- Net worth
- ₹1,991 Cr
- Liabilities ÷ assets
- 32.8%lower means a lighter balance sheet
| Total assets | 2,961 | 2,837 | 2,187 | 1,388 |
|---|---|---|---|---|
| Total liabilities | 970 | 903 | 960 | 826 |
| Net worthderived | 1,991 | 1,934 | 1,227 | 562 |
| Liabilities ÷ assetsderived | 32.8% | 31.8% | 43.9% | 59.5% |
| Asset growthderived | 4.4% | 29.7% | 57.6% | — |
Figures in ₹ crore. Stacked chart height equals total assets.
Full annual line itemsNon-current & current assets, liabilities, equity capitalShowHide
| Non-Current Assets | 2,654 | 2,210 | 1,557 | 1,187 |
|---|---|---|---|---|
| Current Assets | 307 | 627 | 630 | 201 |
| Total Assets | 2,961 | 2,837 | 2,187 | 1,388 |
| Current Liabilities | 309 | 342 | 277 | 213 |
| Net Current Asset | -2 | 285 | 353 | -13 |
| Non-Current Liabilities | 661 | 561 | 683 | 613 |
| Equity Capital | 1,991 | 1,934 | 1,227 | 562 |
| Total Equity & Liabilities | 2,961 | 2,837 | 2,187 | 1,388 |
Figures in ₹ crore unless the line item is per-share.
07/Cash flow
Standalone cash flow
Annual only, in ₹ crore. Negative values are outflows, so healthy companies usually show positive operating and negative investing cash flow.
- Operating · Mar 2026
- ₹321 Cr+55.91% YoY
- Investing
- -₹167 Cr
- Financing
- -₹173 Cr
- Free cash flow
- ₹154 Croperating + investing
| Operating activities | 321 | 206 | 222 | 153 |
|---|---|---|---|---|
| Operating changereported | 55.9% | -7.2% | 45.1% | — |
| Investing activities | -167 | -577 | -818 | -436 |
| Investing changereported | 71.1% | 29.4% | -87.7% | — |
| Financing activities | -173 | 374 | 570 | 316 |
| Financing changereported | -146.1% | -34.4% | 80.5% | — |
| Net cash flowderived | -19 | 2 | -26 | 33 |
| Free cash flowoperating + investing | 154 | -372 | -596 | -283 |
Figures in ₹ crore.
Full annual line itemsProfit before tax through closing cash balanceShowHide
| Profit before tax | 64 | 39 | 45 | -6 |
|---|---|---|---|---|
| Income before WC changes | 332 | 266 | 233 | 169 |
| Change in Assets | -6 | -90 | -33 | -13 |
| Change in Liabilities | 27 | 24 | 34 | 9 |
| Change in WC | 21 | -66 | 2 | -4 |
| Cash flow from Operations | 321 | 206 | 222 | 153 |
| Cash flow from Investing | -167 | -577 | -818 | -436 |
| Cash flow from Financing | -173 | 374 | 570 | 316 |
| Total Cash Flow | -19 | 2 | -26 | 33 |
| Cash (Start of the year) | 54 | 51 | 77 | 44 |
| Cash (End of the year) | 35 | 54 | 51 | 77 |
Figures in ₹ crore unless the line item is per-share.
09/Events
Corporate actions
Dividends, bonuses, splits and rights issues. Filter by type, sort by any date, and expand a row for the full event detail.
No corporate actions on record
10/Comparison
Peers & competitors
Competitor set priced live. Filter by sector, sort any column, and expand a peer for its business description.
| APOLLOHOSPApollo Hospitals Enter. L | Healthcare Services | ₹9,200.00 | +5.29% | 14.13 L | ₹1,32,139 Cr | $14.68B | |
| MAXHEALTHMAX Healthcare INS Ltd | Healthcare Services | ₹1,081.00 | +3.88% | 95.32 L | ₹1,05,080 Cr | $11.68B | |
| MANIPALHOSManipal Health Enterpri L | Healthcare | ₹702.20 | +0.83% | 11.62 L | ₹92,366 Cr | $10.26B | |
| ASTERDMAster DM Quality Care Ltd | Healthcare Services | ₹779.30 | +5.41% | 26.66 L | ₹67,960 Cr | $7.55B | |
| FORTISFortis Healthcare Ltd | Healthcare Services | ₹825.00 | +1.87% | 22.88 L | ₹62,284 Cr | $6.92B | |
| MEDANTAGlobal Health Limited | Healthcare Services | ₹1,480.20 | +0.13% | 2.65 L | ₹39,829 Cr | $4.43B | |
| NHNarayana Hrudayalaya Ltd. | Healthcare Services | ₹1,945.00 | +3.84% | 7.85 L | ₹39,757 Cr | $4.42B | |
| LALPATHLABDR. LAL Path Labs Ltd. | Healthcare Services | ₹1,989.00 | +1.31% | 2.65 L | ₹33,680 Cr | $3.74B | |
| KIMSKrishna Inst Of MED SCI L | Healthcare Services | ₹795.60 | +3.62% | 10.44 L | ₹33,483 Cr | $3.72B | |
| SYNGENESyngene International Ltd | Diversified | ₹451.70 | +3.28% | 25.58 L | ₹18,240 Cr | $2.03B |
Market cap is the sector-constituent figure reported per peer · Showing 1–10 of 10
11/Coverage
Company news
Articles published in the last seven days, paginated by the provider.
No news in the last seven days
Company news is available for a rolling one-week window.